Depression in bipolar disorder is considered the most common mood phase and also a major clinical challenge. This is known to cause impairment from being symptomatic with syndromal or subsyndromal symptoms. For this reason, we should have the knowledge of available FDA-approved medications for bipolar depression.
Psychiatry Education Forum Academy’s most recent video discussion will compare the following five FDA approved medications for bipolar depression:
- Olanzapine + Fluoxetine
Comparing FDA Approved Medications for Bipolar Depression
This 30 minutes video discussion will be summarized in the following 10 clinically relevant sections:
- FDA Approved Indication: Bipolar Depression.
- FDA Approved Indication: Bipolar Disorder Phases (Depression, Mania and Mixed)
- Pediatric Bipolar Disorder FDA Indications.
- Non-Bipolar Psychiatric Indications.
- Bipolar Disorder Guidelines: CANMAT & ISBD (2018)
- Dosing & Need for Titration.
- Renal and Hepatic Impairment.
- CardiaC Risk: QTc & Torsdaes.
- Metabolic Side Effects
- Drug Interactions
HERE IS ONE OF THE SLIDE FROM THIS PRESENTATION:
INTERESTED IN LEARNING MORE?
JOIN PSYCHIATRY EDUCATION FORUM ACADEMY MEMBERSHIP
This is a closed membership for medical professionals only.
- 30+ Courses/Sections: Each chapter within these sections is of direct clinical relevance for your daily practice.
- Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
- Coffee Club: contain short discussions with clinical experts in the field of psychiatry.
- Essentials of Inpatient Psychiatry Book: All chapters from this book are included in the academy sections.
- Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
- Conference Discounts: Academy members get discounted access at our conferences.
- Goal: is to have all important clinically relevant topics in one place for ease of access.
SUBSCRIBE TO OUR EMAIL NEWSLETTER: